Dopamine Transporter Activity Is Modulated by α-Synuclein.

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• The dopamine transporter (DAT) regulates dopaminergic signaling, and its altered activity is linked to addiction and neurodegenerative diseases.
• DAT function is modulated by intracellular proteins, including α-synuclein, a protein implicated in neurodegenerative conditions.
• The precise mechanisms governing the DAT-α-synuclein interaction, its cellular localization, and functional impact remain largely uncharacterized.

Purpose of the Study:

• To investigate the regulatory mechanisms of the DAT-α-synuclein interaction.
• To determine the cellular location of DAT-α-synuclein complex formation.
• To elucidate the functional consequences of this interaction on dopamine transporter activity and membrane distribution.

Main Methods:

• Utilized dopaminergic neurons and mammalian cell models.
• Investigated protein-protein interactions at the plasma membrane.
• Assessed dopamine transporter activity and membrane microdomain localization.

Main Results:

• The majority of DAT·α-synuclein complexes reside at the plasma membrane.
• Amphetamine stimulation increases DAT activity and enhances DAT-α-synuclein association at the plasma membrane.
• DAT-induced membrane depolarization promotes α-synuclein plasma membrane localization, increasing dopamine efflux and DAT enrichment in cholesterol-rich microdomains.

Conclusions:

• The DAT-α-synuclein interaction occurs primarily at the plasma membrane and is dynamically regulated by neuronal activity.
• This interaction plays a crucial role in modulating dopamine transporter function and localization within specific membrane domains.
• Findings provide insights into the molecular mechanisms underlying dopaminergic signaling regulation and its potential relevance to disease.